[{"orgOrder":0,"company":"Verve Medical","sponsor":"RQM+ | Dabl Ltd | Medical Labs Memphis - MLM","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Verve Medical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Verve Medical \/ RQM+ | Dabl Ltd | Medical Labs Memphis - MLM","highestDevelopmentStatusID":"1","companyTruncated":"Verve Medical \/ RQM+ | Dabl Ltd | Medical Labs Memphis - MLM"}]

Find Clinical Drug Pipeline Developments & Deals by Verve Medical

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hypertension.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          June 04, 2025

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : RQM+ | Dabl Ltd | Medical Labs Memphis - MLM

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank